News
The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...
1d
News-Medical.Net on MSNNasal antibody spray shields mice from pollen-triggered allergies and asthmaIntranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...
1d
The Brighterside of News on MSNOxytocin nasal spray shows promise for treating alcoholism and obesityOxytocin, often called the “love hormone” for its role in social bonding and maternal behaviors, is now being investigated for something unexpected—its ability to regulate addictive behaviors and ...
Join over 14,000 individuals and families managing food allergies who are sharing their food allergy stories and making a ...
MARYVILLE/GRANITE CITY/BELLEVILLE - Chestnut Health Systems will offer free virtual NARCAN training.At 10 a.m. and 2 p.m. on ...
A mid-stage trial of BPL‑003 nasal spray shows promising results for treatment-resistant depression, igniting biotech ...
FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support ...
12d
Onlymyhealth on MSNThe Hidden Dangers Of Nasal Polyps: Why A Stuffy Nose Isn't Just A Cold?Learn about nasal polyps a condition that can be mistaken for a common cold and how to identify and treat them effectively ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results